- FDA approves Amgen's treatment for most deadly form of lung cancer on May 16, 2024 at 9:47 pm
The FDA cleared the Amgen drug, called Imdelltra, as a treatment for patients with advanced small-cell lung cancer.
- Roche says weight loss drug shows promising results in early trialon May 16, 2024 at 2:03 pm
The weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after 24 weeks in the phase one trial.
- Danaher's rally shows how sticking with a troubled stock of a good company can pay offon May 15, 2024 at 6:57 pm
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
- Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxoneon May 15, 2024 at 3:37 pm
Walgreens said it will sell a two-dose pack of its naloxone for $34.99, around $10 cheaper than the over-the-counter Narcan nasal spray.
- Healthy Returns: 1 in 8 adults have taken Ozempic or other GLP-1s, survey sayson May 14, 2024 at 7:58 pm
Many Americans are using GLP-1s despite shortages, a survey says. Meanwhile, Google DeepMind's new AI model can predict the structure of molecules.
- It's no surprise to see Amazon shares lower after cloud CEO shakeupon May 14, 2024 at 4:28 pm
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
- People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study sayson May 14, 2024 at 3:16 pm
The results shed light on the long-term effects of Wegovy, and could boost Novo Nordisk's case to insurers and governments to cover the costly drug.
Click Advertiser ♥